Preoperative Bexarotene Treatment for Cushing's Disease
Status:
Unknown status
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The objective of this pilot study is to establish the safety and tolerability of short-term
therapy with bexarotene in patient's with Cushing's disease, and study the clinical,
biochemical, and cellular effects of a preoperative five-day course of bexarotene in these
patients before undergoing transsphenoidal surgery.